Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 2/2008

01-02-2008 | Original Paper

Decreased Histamine Catabolism in the Colonic Mucosa of Patients with Colonic Adenoma

Authors: Michael A. Kuefner, Hubert G. Schwelberger, Eckhart G. Hahn, Martin Raithel

Published in: Digestive Diseases and Sciences | Issue 2/2008

Login to get access

Abstract

Introduction

Alterations in mucosal histamine degradation play an important role in various gastrotinestinal diseases including colonic adenoma. In humans, histamine can be catabolized either by oxidative deamination by diamine oxidase (DAO) or by ring methylation by histamine N-methyltransferase (HNMT). The significance of HNMT in this context was investigated for the first time in this project.

Methods

About 94 colonic biopsies were endoscopically obtained from 23 patients suffering from colonic adenoma and 26 biopsies from six healthy individuals. Each sample was mechanically homogenized, homogenates were cleared by centrifugation and used for determination of protein and histamine concentrations and enzyme activities of DAO and HNMT by radiometric assay.

Results

In adenoma patients DAO activities were slightly and HNMT activities were significantly decreased in normal mucosa compared to controls. Activities of both enzymes were significantly lower in adenoma tissue than in healthy mucosa in the same patients. A significant correlation was found between HNMT and DAO in all investigated samples. Histamine concentrations were elevated in adenoma patients.

Conclusions

Histamine catabolism is decreased in the colonic mucosa of patients with colonic adenoma.
Literature
1.
Markowitz SD, Dawson DM, Willis J, Willson JK (2002) Focus on colon cancer. Cancer Cell 1:233–236PubMedCrossRef
2.
3.
Seitz HK, Simanowski UA, Homann N, Waldherr R (1998) Cell proliferation and its evaluation in the colorectal mucosa: effect of ethanol. Z Gastroenterol 36:645–655PubMed
4.
Prichard PJ, Tjandra JJ (1998) Colorectal cancer. Med J Aust 169:493–498PubMed
5.
Hardy RG, Meltzer SJ, Jankowski JA (2000) ABC of colorectal cancer. Molecular basis for risk factors. BMJ 321:886–889PubMedCrossRef
6.
Leslie A, Carey FA, Pratt NR, Steele RJC (2002) The colorectal adenoma-carcinoma sequence. Br J Surg 89:845–860PubMedCrossRef
7.
Villavicencio RT, Rex DK (2000) Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy. Semin Gatrointest Dis 11:185–193
8.
Srivastava S, Verma M, Henson DE (2001) Biomarkers for early detection of colon cancer. Clin Cancer Res 7:1118–1126PubMed
9.
Kusche J, Mennigen R, Leisten L (1989) Early alterations of rat intestinal diamine oxidase activity by azoxymethane, an intestinal carcinogen. Agents Actions 27:218–220PubMedCrossRef
10.
Raithel M, Ulrich P, Hochberger J, Hahn EG (1998) Measurement of gut diamine oxidase activity: diamine oxidase as a new biologic marker of colorectal proliferation? Ann NY Acad Sci 859:262–266PubMedCrossRef
11.
12.
Norrby K (1985) Evidence of mast-cell histamine being mitogenic in intact tissue. Agents Actions 16:287–290PubMedCrossRef
13.
Argento-Cerú MP, Autouri F (1985) Localization of diamine oxidase in animal tissues. In: Mondovi B (ed) Structure and functions of amine oxidases. CRC Press, Boca Raton pp 89–104
14.
Kusche J, Mennigen R, Erpenbach K (1988) The intestinal diamine oxidase activity under the influence of adaptive proliferation of the intestinal mucosa – a proliferation terminating principle? Agents Actions 23:354–356PubMedCrossRef
15.
Code CF (1985) Histamine – whither now? Can J Physiol Pharmacol 63:746–750PubMed
16.
Kusche J, Mennigen R, Leisten L, Krakamp B (1988) Large bowel tumour promotion by diamine oxidase inhibition: animal model and clinical aspects. Adv Exp Med Biol 250:745–752PubMed
17.
Pacifici GM, Donatelli P, Giuliani L (1992) Histamine N-methyltransferase: inhibition by drugs. Br J Clin Pharmac 34:322–327
18.
Sattler J, Hesterberg R, Lorenz W, Schmidt U, Crombach M (1985) Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects? Agents Actions 16:91–94PubMedCrossRef
19.
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):15076–15085CrossRef
20.
Kusche J, Richter H, Hesterberg R, Schmidt J, Lorenz W (1973) Comparison of the 14C-Putrescine assay with the NADH test for the determination of diamine oxidase: description of a standard procedure with a high precision and an improved accuracy. Agents Actions 3:148–156PubMedCrossRef
21.
Schwelberger HG, Klocker J, Sattler J, Bodner E (1995) Determination of the activity of diamine oxidase in extremely small tissue samples. Inflamm Res 44:94–95CrossRef
22.
Brown DD, Tomchick R, Axelrod J (1959) The distribution and properties of a histamine-methylating enzyme. J Biol Chem 234:2948–2950PubMed
23.
Barth H, Lorenz W, Niemeyer I (1973) Inhibition and activation of histamine methyltransferase by methylated histamines. Hoppe Seylers Z Physiol Chem 354:1021–1026PubMed
24.
Beaven MA, Robinson-White A, Roderick NB, Kauffmann GL (1982) The demonstration of histamine release in clinical conditions: a review of past and present assay procedures. Klin Wochenschr 60:873–881PubMedCrossRef
25.
Verburg KM, Bowsher RR, Henry DP (1983) A new radioenzymatic assay for histamine using purified histamine N-methyltransferase. Life Sci 32:2855–2867PubMedCrossRef
26.
Kufner MA, Ulrich P, Raithel M, Schwelberger HG (2001) Determination of the histamine degradation capacity in extremely small human colon samples. Inflamm Res 50(Suppl 2):96–97
27.
Hesterberg R, Sattler J, Lorenz W, Stahlknecht CD, Barth H, Crombach M (1984) Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: fact or fictions? Agents Actions 14:325–334PubMedCrossRef
28.
Schwelberger HG, Bodner E (1997) Purification and characterization of diamine oxidase from porcine kidney and intestine. Biochim Biophys Acta 1340:152–164PubMed
29.
Brown DD, Tomchick R, Axelrod J (1959) The distribution and properties of a histamine-methylating enzyme. J Biol Chem 234:2948–2950PubMed
30.
Raithel M, Horauf AM, Matek M, Baenkler HW (1989) Kinetics of histamine released from rectal mucosa. Agents Actions 28:164–167PubMedCrossRef
31.
Backhaus B, Weidenhiller M, Bijlsma P, Hahn EG, Raithel M (2004) Evaluation of spontaneous histamine release from colorectal mucosa in patients with colorectal adenoma, patients with gastrointestinally mediated allergy and in a healthy control group. Inflamm Res 53(Suppl 1):87–88CrossRef
32.
Petersen J, Raithel M, Schwelberger HG (2002) Histamine N-methyltransferase and diamine oxidase gene polymorphisms in patients with inflammatory and neoplasitc intstinal dieases. Inflamm Res 51(Suppl 1):91–92
33.
Adams WJ, Lawson JA, Morris DL (1994) Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 35:1632–1636PubMedCrossRef
34.
Watson SA, Wilkinson LJ, Robertson JFR, Hardcastle JD (1993) Effect of histamine on the growth of human gastrointestinal tumour: reversal by cimetidine. Gut 34:1091–1096PubMedCrossRef
35.
Bodmer S, Imark C, Kneubühl M (1999) Biogenic amines in food: histamine and food processing. Inflamm res 48:296–300PubMedCrossRef
36.
Wantke F, Jarisch J, Götz M (1993) Histamine-free diet: treatment of choice for histamine-induced food intolerance and supporting treatment for chronic headaches. Clin Exp Allergy 23:982–985PubMedCrossRef
37.
Raithel M, Kufner M, Ulrich P, Hahn EG (1999) The involvement of the histamine degradation pathway by diamine oxidase in manifest gastrointestinal allergies. Inflamm Res 48(Suppl 1):75–76CrossRef
38.
Weidenhiller M, Raithel M, Winterkamp S, Otte P, Stolper J, Hahn EG (2000) Methylhistamine in Crohn´s disease (CD): increased production and elevated urine excretion correlates with disease activity. Inflamm Res 49(Suppl 1):35–36CrossRef
Metadata
Title
Decreased Histamine Catabolism in the Colonic Mucosa of Patients with Colonic Adenoma
Authors
Michael A. Kuefner
Hubert G. Schwelberger
Eckhart G. Hahn
Martin Raithel
Publication date
01-02-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9861-x

Other articles of this Issue 2/2008

Digestive Diseases and Sciences 2/2008 Go to the issue

Original Paper

Does Mutation of Hepatitis A Virus Exist in North India?

Original Paper

α-Melanocyte-Stimulating Hormone Gene Transfer Attenuates Inflammation after Bile Duct Ligation in the Rat

Original Paper

13C-Urea Breath Test Values and Helicobacter pylori Eradication

Original Paper

Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder Cancer

Original Paper

Clinical Outcomes of Patients with Liver Cirrhosis Who Underwent Curative Surgery for Gastric Cancer: A Retrospective Multi-center Study

Original Paper

Clinical Features and Outcome of Chronic Viral Hepatitis with Acute Exacerbation in Patients with Concurrent Infections of Hepatitis B and C Virus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits